Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 308 entries
View as:

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor

Phase: N/A Priority: Normal
NCT ID: NCT01362972 Org: User:
Start: 03/31/11 End: 06/30/16 Due: 06/30/17

Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT01024998 Org: User:
Start: 01/11/10 End: 07/31/18 Due: 07/31/19

Aminopterin in Treating Patients With Refractory Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003305 Org: User:
Start: 07/31/97 End: 09/30/07 Due: 09/30/08

A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00454350 Org: User:
Start: 02/28/07 End: 07/31/07 Due: 07/31/08

AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS

Phase: N/A Priority: Normal
NCT ID: NCT00396968 Org: User:
Start: - End: - Due: -

A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01090167 Org: User:
Start: 02/28/10 End: 04/30/11 Due: 04/30/12

Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT00508001 Org: User:
Start: 07/31/07 End: 06/30/09 Due: 06/30/10

Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00078455 Org: User:
Start: 12/31/03 End: 08/31/05 Due: 08/31/06

This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

Phase: N/A Priority: Normal
NCT ID: NCT00720603 Org: User:
Start: - End: - Due: -

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00206674 Org: User:
Start: 09/30/04 End: 06/30/06 Due: 06/30/07

A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus

Phase: N/A Priority: Normal
NCT ID: NCT00361101 Org: User:
Start: 10/31/05 End: 04/30/10 Due: 04/30/11

Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease

Phase: N/A Priority: Normal
NCT ID: NCT00113035 Org: User:
Start: 05/31/05 End: 10/31/05 Due: 10/31/06

AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF

Phase: N/A Priority: Normal
NCT ID: NCT00396266 Org: User:
Start: 01/31/05 End: 12/31/07 Due: 12/31/08

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Phase: N/A Priority: Normal
NCT ID: NCT02554773 Org: User:
Start: 09/18/15 End: 03/21/23 Due: 03/21/24

Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00659438 Org: User:
Start: 02/29/08 End: 07/31/11 Due: 07/31/12

A Prospective, Observational Study in Patients With Late-Onset Pompe Disease

Phase: N/A Priority: Normal
NCT ID: NCT00077662 Org: User:
Start: 03/31/04 End: 01/31/06 Due: 01/31/07

Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00542828 Org: User:
Start: 10/31/07 End: 07/31/09 Due: 07/31/10

A Study of RG-012 in Subjects With Alport Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03373786 Org: User:
Start: 12/22/17 End: 05/20/19 Due: 05/20/20

A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.

Phase: N/A Priority: Normal
NCT ID: NCT00288470 Org: User:
Start: 06/30/02 End: 08/31/03 Due: 08/31/04

Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00098345 Org: User:
Start: 11/30/04 End: 04/19/17 Due: 04/19/18

A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care

Phase: N/A Priority: Normal
NCT ID: NCT00081900 Org: User:
Start: 03/31/04 End: 11/30/07 Due: 11/30/08

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03417102 Org: User:
Start: 02/14/18 End: 06/23/21 Due: 06/23/22

A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT00220311 Org: User:
Start: 11/30/00 End: 09/30/05 Due: 09/30/06

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00322491 Org: User:
Start: 03/31/04 End: 06/30/06 Due: 06/30/07

A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02906020 Org: User:
Start: 12/15/16 End: 05/27/21 Due: 05/27/22